These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28107536)

  • 1. Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2017; 12(1):e0170833. PubMed ID: 28107536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis.
    Liu K; Zheng D; Xu G; Du Z; Wu S
    PLoS One; 2018; 13(4):e0196618. PubMed ID: 29689114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
    Schmidt LH; Brand C; Stucke-Ring J; Schliemann C; Kessler T; Harrach S; Mohr M; Görlich D; Marra A; Hillejan L; Müller-Tidow C; Lenz G; Wardelmann E; Wiewrodt R; Berdel WE; Schwöppe C; Hartmann W
    PLoS One; 2017; 12(8):e0183201. PubMed ID: 28793330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
    Sardaro A; Saito K; Nakayama E; Valmori D
    PLoS One; 2016; 11(7):e0160538. PubMed ID: 27467222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Methylation Markers for the Identification of Body Fluids and Tissues from Forensic Trace Evidence.
    Forat S; Huettel B; Reinhardt R; Fimmers R; Haidl G; Denschlag D; Olek K
    PLoS One; 2016; 11(5):e0156472. PubMed ID: 27219355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer.
    Kuzumaki N; Suzuki A; Narita M; Hosoya T; Nagasawa A; Imai S; Yamamizu K; Morita H; Suzuki T; Okada Y; Okano HJ; Yamashita JK; Okano H; Narita M
    PLoS One; 2013; 8(8):. PubMed ID: 29220846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
    Shen G; Lan Y; Zhang K; Ren P; Jia Z
    PLoS One; 2017; 12(4):e0176150. PubMed ID: 28406970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Correlation between image characteristics and pathologic findings in non small cell lung cancer patients after anatomic resection.
    Fu JY; Wan YL; Huang TY; Wu CF; Liu YH; Hsieh MJ; Wu YC; Wu CY
    PLoS One; 2019; 14(2):e0212461. PubMed ID: 30753242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Transforming growth factor beta 1 induces methylation changes in lung fibroblasts.
    PLOS ONE Staff
    PLoS One; 2019; 14(10):e0224841. PubMed ID: 31665184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
    Circu M; Cardelli J; Barr MP; O'Byrne K; Mills G; El-Osta H
    PLoS One; 2018; 13(5):e0197016. PubMed ID: 29718985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA.
    Li Y; Appius A; Pattipaka T; Feyereislova A; Cassidy A; Ganti AK
    PLoS One; 2019; 14(2):e0212831. PubMed ID: 30785951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.
    Barr MP; Gray SG; Hoffmann AC; Hilger RA; Thomale J; O'Flaherty JD; Fennell DA; Richard D; O'Leary JJ; O'Byrne KJ
    PLoS One; 2020; 15(5):e0233739. PubMed ID: 32437439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: correlation of the apparent diffusion coefficient (ADC) with the Standardized Uptake Value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.
    PLOS ONE Staff
    PLoS One; 2015; 10(3):e0122545. PubMed ID: 25807190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis.
    Schad F; Thronicke A; Steele ML; Merkle A; Matthes B; Grah C; Matthes H
    PLoS One; 2022; 17(8):e0273387. PubMed ID: 35972953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2018; 13(4):e0196354. PubMed ID: 29672617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Celecoxib enhances the sensitivity of non-small-cell lung cancer cells to radiation-induced apoptosis through downregulation of the Akt/mTOR signaling pathway and COX-2 expression.
    PLOS ONE Staff
    PLoS One; 2019; 14(10):e0224843. PubMed ID: 31665187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Aberrant DNA Methylation: Implications in Racial Health Disparity.
    Wang X; Ji P; Zhang Y; LaComb JF; Tian X; Li E; Williams JL
    PLoS One; 2016; 11(6):e0158251. PubMed ID: 27326861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer.
    Hao H; Maeda Y; Fukazawa T; Yamatsuji T; Takaoka M; Bao XH; Matsuoka J; Okui T; Shimo T; Takigawa N; Tomono Y; Nakajima M; Fink-Baldauf IM; Nelson S; Seibel W; Papoian R; Whitsett JA; Naomoto Y
    PLoS One; 2024; 19(7):e0307052. PubMed ID: 38980851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: 2'-O-methylation of the mRNA cap protects RNAs from decapping and degradation by DXO.
    Picard-Jean F; Brand C; Tremblay-Létourneau M; Allaire A; Beaudoin MC; Boudreault S; Duval C; Rainville-Sirois J; Robert F; Pelletier J; Geiss BJ; Bisaillon M
    PLoS One; 2018; 13(8):e0202308. PubMed ID: 30092053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Whole-Genome Saliva and Blood DNA Methylation Profiling in Individuals with a Respiratory Allergy.
    Langie SAS; Szarc Vel Szic K; Declerck K; Traen S; Koppen G; Van Camp G; Schoeters G; Berghe WV; De Boever P
    PLoS One; 2017; 12(8):e0183088. PubMed ID: 28787008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.